Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|June 24, 2010
Optimization of isochromanone based urotensin II receptor agonistsFredrik Lehmann, Erika A Currier, Roger Olsson, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 26, 2011
II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptorsEthan S Burstein, Maria L Carlsson, Michelle Owens, et al.Schizophrenia Research|September 8, 2012
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/dayHerbert Y Meltzer, Helio Elkis, Kimberly Vanover, et al.Molecular Pharmacology|October 26, 2007
Constitutively active mutants of the histamine H1 receptor suggest a conserved hydrophobic asparagine-cage that constrains the activation of class A G protein-coupled receptorsRemko A Bakker, Aldo Jongejan, Kamonchanok Sansuk, et al.Journal of Medicinal Chemistry|November 24, 2005
Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonistBirgitte W Lund, Fabrice Piu, Natalie K Gauthier, et al.Biochemical Pharmacology|November 24, 2005
Identification of novel subtype selective RAR agonistsFabrice Piu, Natalie K Gauthier, Roger Olsson, et al.Biochemical Pharmacology|March 24, 2004
Pharmacology of polymorphic variants of the human 5-HT1A receptorAndria L Del Tredici, Hans H Schiffer, Ethan S Burstein, et al.Molecular Pharmacology|May 22, 2002
Discovery of an ectopic activation site on the M(1) muscarinic receptorTracy A Spalding, Carol Trotter, Niels Skjaerbaek, et al.The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.Journal of Medicinal Chemistry|November 1, 2002
Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954)Glenn E Croston, Roger Olsson, Erika A Currier, et al.Pageof 3